Stockreport

Immune Design Announces Program Updates & Portfolio Prioritization for G100 and CMB305

IMMUNE DESIGN CORP COMMON STOCK  (IMDZ) 
Last immune design corp common stock earnings: 11/6 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.immunedesign.com/investor-relations
PDF G100 development to accelerate in follicular lymphoma and beyondCMB305 to be deprioritized to support focus on G100Cash runway extended into 2021Conference call at 2:00 [Read more]